Literature DB >> 26790576

Prevalence of depression in type 2 diabetes patients in German primary care practices.

Louis Jacob1, Karel Kostev2.   

Abstract

AIMS: To analyse depression in German type 2 diabetes patients with or without diabetes complications.
METHODS: Longitudinal data from nationwide general practices in Germany (n=1,202) were analysed. People initially diagnosed with type 2 diabetes (2004-2013) were identified and 90,412 patients were included (age: 65.5 years, SD: 11.7). The main outcome measure was the first diagnosis of depression (ICD 10: F32, F33) within ten years after index date in patients with and without diabetes complications. Cox proportional hazards models were used to adjust for confounders.
RESULTS: At baseline, most patients had diabetes complications and 6.4% of them had private insurance. Ten years after type 2 diabetes diagnosis, 30.3% of patients showed symptoms of depression. The prevalence of depression was higher in women than in men (33.7% versus 26.8%), in patients with high HbA1c levels (31.3% when Hb1Ac ≥ 9 versus 27.5% when HbA1c < 7) and in patients with diabetes complications (37.7% when there were more than two complications versus 29.1% when there were no complications). Women and patients without private health insurance were at a higher risk of developing depression. Retinopathy, neuropathy, nephropathy, coronary heart disease, stroke and HbA1c levels higher than 7 were also positively associated with depression.
CONCLUSIONS: Diabetes complications and high HbA1c levels had a substantial impact on depression in primary care patients with type 2 diabetes.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes; Macrovascular disease; Microvascular disease; Prevalence; Primary care; Psychosocial stressors

Mesh:

Substances:

Year:  2015        PMID: 26790576     DOI: 10.1016/j.jdiacomp.2015.12.013

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  8 in total

1.  Seasonality of Insulin Use in German Outpatients With Diabetes: A Retrospective Analysis.

Authors:  Karel Kostev; Sarah Gläser; Louis Jacob
Journal:  J Diabetes Sci Technol       Date:  2017-04-18

2.  Impact of Disease Management Programs on HbA1c Values in Type 2 Diabetes Patients in Germany.

Authors:  Karel Kostev; Timo Rockel; Louis Jacob
Journal:  J Diabetes Sci Technol       Date:  2016-07-10

3.  Prescription Patterns and the Cost of Antihyperglycemic Drugs in Patients With Type 2 Diabetes Mellitus in Germany.

Authors:  Louis Jacob; Christian von Vultee; Karel Kostev
Journal:  J Diabetes Sci Technol       Date:  2016-07-11

4.  Risk of Nonfatal Stroke in Type 2 Diabetes Mellitus Patients: A Retrospective Comparison Between Disease Management Programs and Standard Care.

Authors:  Stefan Wiefarn; Christian Heumann; Anja Rettelbach; Karel Kostev
Journal:  J Diabetes Sci Technol       Date:  2017-02-09

5.  Depression risk in patients with late-onset rheumatoid arthritis in Germany.

Authors:  Julia Drosselmeyer; Louis Jacob; Wolfgang Rathmann; Michael A Rapp; Karel Kostev
Journal:  Qual Life Res       Date:  2016-08-08       Impact factor: 4.147

6.  The association between insulin therapy and depression in patients with type 2 diabetes mellitus: a meta-analysis.

Authors:  Xiaosu Bai; Zhiming Liu; Zhisen Li; Dewen Yan
Journal:  BMJ Open       Date:  2018-11-28       Impact factor: 2.692

7.  Prevalence and Associated Factors of Diabetes Distress, Depression and Anxiety Among Primary Care Patients With Type 2 Diabetes During the COVID-19 Pandemic in Egypt: A Cross-Sectional Study.

Authors:  Hazem A Sayed Ahmed; Ahmed Mahmoud Fouad; Sally Fawzy Elotla; Anwar I Joudeh; Mona Mostafa; Asghar Shah; Jaffer Shah; Samar F Mohamed
Journal:  Front Psychiatry       Date:  2022-06-03       Impact factor: 5.435

8.  Central Nervous System Correlates of "Objective" Neuropathy in Alcohol Use Disorder.

Authors:  Natalie M Zahr; Kilian M Pohl; Adolf Pfefferbaum; Edith V Sullivan
Journal:  Alcohol Clin Exp Res       Date:  2019-08-23       Impact factor: 3.455

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.